Fluoropyrimidine-based Chemotherapy

DRUG2 trials

Sponsors

Hoffmann-La Roche, Tang-Du Hospital

Conditions

Colorectal CancerPancreatic Cancer

Phase 2

Retlirafusp Alfa Plus Apatinib and Chemotherapy as Second-Line Treatment for Pancreatic Cancer

Not yet recruitingNCT07773363

Tang-Du HospitalPancreatic Cancer

Start: 2026-08-30End: 2028-12-30Target: 37Updated: 2026-08-19

Phase 3

A Study of Bevacizumab (Avastin) in Combination With Chemotherapy in Participants With Metastatic Cancer of the Colon or Rectum.

CompletedNCT01169558

Hoffmann-La RocheColorectal Cancer

Start: 2006-05-31End: 2009-07-31Updated: 2016-12-08